Heterogeneity in potential impact and cost-effectiveness of ETEC and Shigella vaccination in four sub-Saharan African countries

by John D. Anderson, IV, Farzana Muhib, Richard Rheingans, Thomas Wierzba
Published 2019-12-01

Shigella and childhood stunting: Evidence, gaps, and future research directions.

by Karoun H Bagamian, John D Anderson Iv, Gabriela Blohm, Suzanne Scheele
Published 2023-09-01

Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries

by John D. Anderson, IV, Karoun H. Bagamian, Farzana Muhib, Ranju Baral, Lindsey A. Laytner, Mirna Amaya, Thomas Wierzba, Richard Rheingans
Published 2019-08-01

Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis

by John D Anderson, IV, PhD, Karoun H Bagamian, PhD, Farzana Muhib, MPH, Mirna P Amaya, MPH, Lindsey A Laytner, MPH, Thomas Wierzba, PhD, Richard Rheingans, PhD
Published 2019-03-01

Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, morta...

by Karoun H Bagamian, PhD, John D Anderson, IV, PhD, Farzana Muhib, MPH, Oliver Cumming, MSc, Lindsey A Laytner, PhD, Thomas F Wierzba, ProfPhD, Richard Rheingans, ProfPhD
Published 2020-01-01

Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021

by Karoun H. Bagamian, Chloe Puett, John D. Anderson, IV, Farzana Muhib, Clint Pecenka, Jere Behrman, Robert F. Breiman, Ijeoma Edoka, Susan Horton, Gagandeep Kang, Karen L. Kotloff, Claudio F. Lanata, James A. Platts-Mills, Firdausi Qadri, Elizabeth T. Rogawski McQuade, Christopher Sudfeld, Pascale Vonaesch, Thomas F. Wierzba, Suzanne Scheele
Published 2022-12-01